Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Despite untiring efforts to develop therapies for pancreatic ductal adenocarcinoma (PDAC), survival statistics remain dismal, necessitating distinct approaches. Photodynamic priming (PDP), which improves drug delivery and combination regimens, as well as tumor photodestruction are key attributes of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nano Lett
Autores principales: Obaid, Girgis, Bano, Shazia, Mallidi, Srivalleesha, Broekgaarden, Mans, Kuriakose, Jerrin, Silber, Zachary, Bulin, Anne-Laure, Wang, Yucheng, Mai, Zhiming, Jin, Wendong, Simeone, Diane, Hasan, Tayyaba
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934365/
https://ncbi.nlm.nih.gov/pubmed/31518145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.nanolett.9b00859
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares